Ideagen PLC Board Changes (6223R)

TIDMIDEA

RNS Number : 6223R

Ideagen PLC

01 July 2020

July 1(st) 2020

Ideagen PLC

("Ideagen" "the Company" or "the Group")

Board Change

Ideagen PLC (AIM: IDEA), a leading supplier of integrated risk management software to highly regulated industries, is pleased to confirm that Emma Hayes has today joined the Group as Chief Financial Officer, succeeding Graeme Spenceley, as announced on 7(th) January 2020.

Graeme has retired as a Director but will remain with the Group as Company Secretary and financial advisor to the Board. This role will be on a full-time basis until 31 October 2020 which will provide for a full and effective handover to Emma, and thereafter he will continue in that capacity on a part-time basis.

Emma was previously Group Finance Director, Capital Delivery and Commercial, at Severn Trent PLC having held the position since 2017. In this role she controlled a P&L and Balance Sheet of approximately GBP600m and was responsible for driving operational efficiencies through her 100-strong team. Before that Emma spent 10 years with Deloitte LLP as a Corporate Finance Director where she led origination and execution of a wide range of M&A transactions. Emma qualified as a Chartered Accountant (ACA) with BDO.

Graeme Spenceley was previously awarded 750,000 share options under the Company's 2018 LTIP scheme (as announced on 29 March 2019 with details of the relevant scheme announced on 23 October 2018). The Board and Graeme have agreed that this award will be reduced to 187,500 options and that these will vest in full on the achievement of the first performance criteria (being the Company's share price reaching 196 pence over 30 consecutive business days).

Emma has in turn been awarded 562,500 share options under the 2018 LTIP with the same vesting conditions such that 187,500 of these options becoming eligible to vest on the first performance criterion described above being met, with the remainder becoming eligible to vest on the Company's share price reaching 259 pence over 30 consecutive business days. All other terms and conditions relating to the 2018 LTIP as previously described apply equally.

Ben Dorks, Chief Executive of Ideagen, commented ; "Firstly, the Board would like thank Graeme for his outstanding commitment to Ideagen. His insight, acumen and support over the past 10 years has been invaluable and it has been a great pleasure to work alongside him. We are pleased that Graeme will remain with the business as Company Secretary which will provide for a robust transition.

The Board is delighted to welcome Emma to the Group who brings with her a deep understanding of both financial structures and processes and M&A. We will benefit hugely from Emma's experience and ability as Ideagen continues to execute its global growth strategy."

There are no further disclosures to be made in relation to Emma Jane Hayes, aged 39, pursuant to Schedule 2(g) of the AIM Rules for Companies. .

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (MAR).

Enquiries:

 
Ideagen plc                                   01629 699100 
David Hornsby, Executive Chairman 
Ben Dorks, Chief Executive Officer 
Graeme Spenceley, Chief Financial Officer 
 
 finnCap Limited                              020 7220 0500 
Henrik Persson/James Thompson/ Hannah Boros 
 (Nomad) 
Alice Lane (ECM) 
Canaccord Genuity Limited                      020 7523 8000 
Simon Bridges 
Richard Andrews 
 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com

 
 1.   Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name:                              Emma Hayes 
     ---------------------------------  ------------------------------------ 
 2.   Reason for the notification 
     ----------------------------------------------------------------------- 
 a)   Position/status:                   Chief Financial Officer 
     ---------------------------------  ------------------------------------ 
 b)   Initial notification/Amendment:    Initial Notification 
     ---------------------------------  ------------------------------------ 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ----------------------------------------------------------------------- 
 a)   Name:                              Ideagen plc 
     ---------------------------------  ------------------------------------ 
 b)   LEI:                               213800KS1MLITOVNYC85 
     ---------------------------------  ------------------------------------ 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ----------------------------------------------------------------------- 
 a)   Description of the financial       Ordinary shares of 0.1p 
       instrument, type of instrument: 
       Identification code:               GB00B0CM0C50 
     ---------------------------------  ------------------------------------ 
 b)   Nature of the transaction:         Grant of LTIPs over Ordinary Shares 
     ---------------------------------  ------------------------------------ 
 c)   Price(s) and volume(s):             Price(s)    Volume(s) 
                                           n/a         562,500 
                                                      ---------- 
     ---------------------------------  ------------------------------------ 
 d)   Aggregated information:            See 4 (c) above 
        *    Aggregated volume: 
 
 
        *    Price: 
     ---------------------------------  ------------------------------------ 
 e)   Date of the transaction:           1 July 2020 
     ---------------------------------  ------------------------------------ 
 f)   Place of the transaction:          Off market 
     ---------------------------------  ------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCFFFEIRLIIVII

(END) Dow Jones Newswires

July 01, 2020 02:00 ET (06:00 GMT)